Gilles LAVERNY

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Raffaella Maria Gadaleta, Karel J. van Erpecum, Bas Oldenburg et al. · Gut · 2011 · 851 citations

Life Sciences, Immunology, Pharmacology +17

Androgen signaling negatively controls group 2 innate lymphoid cells

Sophie Laffont, Eve Blanquart, Magali Savignac et al. · The Journal of Experimental Medicine · 2017 · 276 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Human Benign Prostatic Hyperplasia Stromal Cells As Inducers and Targets of Chronic Immuno-Mediated Inflammation

Giuseppe Penna, Benedetta Fibbi, Susana Amuchastegui et al. · The Journal of Immunology · 2009 · 176 citations · Full text

Life Sciences, Immunology, Urology +17

IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis

Alain Meyer, Gilles LAVERNY, Yves Allenbach et al. · Acta Neuropathologica · 2017 · 125 citations

Life Sciences, Cell Biology, Immunology +16

The vitamin D receptor agonist elocalcitol inhibits IL‐8‐dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF‐kB pathways

Giuseppe Penna, Benedetta Fibbi, Susana Amuchastegui et al. · The Prostate · 2008 · 112 citations

Medicine, Pharmacology, Urology +17